| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.4B | $3.6B | $3.3B | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.6B | $0.5B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.2B | $0.3B | $0.3B | $0.2B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $0.03 | $7.43 | $12.18 | $11.15 | $7.57 | $1.22 | $1.22 | $1.17 |
| EPS (Diluted) | $0.03 | $7.40 | $12.09 | $10.92 | $7.37 | $1.19 | $1.20 | $1.16 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.8B | $7.9B | $7.1B | $6.0B | $4.5B | $3.6B | $3.8B | $3.6B |
| Current Assets | $1.0B | $0.8B | $0.7B | $0.6B | $0.5B | $0.4B | $0.4B | $0.4B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $11.8B | $6.5B | $5.8B | $4.8B | $3.5B | $2.8B | $3.2B | $3.0B |
| Current Liabilities | $0.7B | $0.6B | $0.5B | $0.6B | $0.5B | $0.3B | $0.3B | $0.3B |
| Stockholders' Equity | $1.9B | $1.4B | $1.3B | $1.1B | $1.0B | $0.7B | $0.6B | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.2B | $1.1B | $0.9B | $0.7B | $0.6B | $0.6B | $0.6B |
| Investing Cash Flow | $-4.9B | $-1.5B | $-1.6B | $-1.7B | $-1.0B | $-0.2B | $-0.5B | $-0.6B |
| Capital Expenditures | $0.2B | $0.2B | $0.2B | $0.1B | $0.0B | $0.0B | $0.1B | $0.1B |
| Financing Cash Flow | $3.8B | $0.3B | $0.5B | $0.8B | $0.2B | $-0.4B | $-0.2B | $-0.0B |